Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof

Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof

US Patent 11357781 · Granted Jun 14, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of extracellular signal-regulated kinase2025
Inhibitors of extracellular signal-regulated kinase2025
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2025
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2025
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2025
Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial2024
Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial2024
Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial2024
Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothe2024
Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothe2024
Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothe2024
Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors2023